249 related articles for article (PubMed ID: 24463168)
61. A cationic prodrug/therapeutic gene nanocomplex for the synergistic treatment of tumors.
Lu X; Wang QQ; Xu FJ; Tang GP; Yang WT
Biomaterials; 2011 Jul; 32(21):4849-56. PubMed ID: 21458064
[TBL] [Abstract][Full Text] [Related]
62. Novel local drug delivery system using thermoreversible gel in combination with polymeric microspheres or liposomes.
Arai T; Benny O; Joki T; Menon LG; Machluf M; Abe T; Carroll RS; Black PM
Anticancer Res; 2010 Apr; 30(4):1057-64. PubMed ID: 20530409
[TBL] [Abstract][Full Text] [Related]
63. Potentiation of a topoisomerase I inhibitor, karenitecin, by the histone deacetylase inhibitor valproic acid in melanoma: translational and phase I/II clinical trial.
Daud AI; Dawson J; DeConti RC; Bicaku E; Marchion D; Bastien S; Hausheer FA; Lush R; Neuger A; Sullivan DM; Munster PN
Clin Cancer Res; 2009 Apr; 15(7):2479-87. PubMed ID: 19318485
[TBL] [Abstract][Full Text] [Related]
64. The histone deacetylase inhibitor valproic acid sensitizes human and canine osteosarcoma to doxorubicin.
Wittenburg LA; Bisson L; Rose BJ; Korch C; Thamm DH
Cancer Chemother Pharmacol; 2011 Jan; 67(1):83-92. PubMed ID: 20306194
[TBL] [Abstract][Full Text] [Related]
65. A novel doxorubicin-mitomycin C co-encapsulated nanoparticle formulation exhibits anti-cancer synergy in multidrug resistant human breast cancer cells.
Shuhendler AJ; Cheung RY; Manias J; Connor A; Rauth AM; Wu XY
Breast Cancer Res Treat; 2010 Jan; 119(2):255-69. PubMed ID: 19221875
[TBL] [Abstract][Full Text] [Related]
66. Cargo-Free Nanomedicine with pH Sensitivity for Codelivery of DOX Conjugated Prodrug with SN38 To Synergistically Eradicate Breast Cancer Stem Cells.
Sun N; Zhao C; Cheng R; Liu Z; Li X; Lu A; Tian Z; Yang Z
Mol Pharm; 2018 Aug; 15(8):3343-3355. PubMed ID: 29923726
[TBL] [Abstract][Full Text] [Related]
67. Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy.
Li L; ten Hagen TL; Hossann M; Süss R; van Rhoon GC; Eggermont AM; Haemmerich D; Koning GA
J Control Release; 2013 Jun; 168(2):142-50. PubMed ID: 23524188
[TBL] [Abstract][Full Text] [Related]
68. Combination of measles virus virotherapy and radiation therapy has synergistic activity in the treatment of glioblastoma multiforme.
Liu C; Sarkaria JN; Petell CA; Paraskevakou G; Zollman PJ; Schroeder M; Carlson B; Decker PA; Wu W; James CD; Russell SJ; Galanis E
Clin Cancer Res; 2007 Dec; 13(23):7155-65. PubMed ID: 18056196
[TBL] [Abstract][Full Text] [Related]
69. Conjugate of Pt(IV)-histone deacetylase inhibitor as a prodrug for cancer chemotherapy.
Yang J; Sun X; Mao W; Sui M; Tang J; Shen Y
Mol Pharm; 2012 Oct; 9(10):2793-800. PubMed ID: 22953987
[TBL] [Abstract][Full Text] [Related]
70. The synthesis of a prodrug of doxorubicin designed to provide reduced systemic toxicity and greater target efficacy.
Garsky VM; Lumma PK; Feng DM; Wai J; Ramjit HG; Sardana MK; Oliff A; Jones RE; DeFeo-Jones D; Freidinger RM
J Med Chem; 2001 Nov; 44(24):4216-24. PubMed ID: 11708923
[TBL] [Abstract][Full Text] [Related]
71. A doxorubicin-CNGRC-peptide conjugate with prodrug properties.
van Hensbergen Y; Broxterman HJ; Elderkamp YW; Lankelma J; Beers JC; Heijn M; Boven E; Hoekman K; Pinedo HM
Biochem Pharmacol; 2002 Mar; 63(5):897-908. PubMed ID: 11911842
[TBL] [Abstract][Full Text] [Related]
72. Valproic Acid prolongs survival time of severe combined immunodeficient mice bearing intracerebellar orthotopic medulloblastoma xenografts.
Shu Q; Antalffy B; Su JM; Adesina A; Ou CN; Pietsch T; Blaney SM; Lau CC; Li XN
Clin Cancer Res; 2006 Aug; 12(15):4687-94. PubMed ID: 16899619
[TBL] [Abstract][Full Text] [Related]
73. QbD-based development of α-linolenic acid potentiated nanoemulsion for targeted delivery of doxorubicin in DMBA-induced mammary gland carcinoma: in vitro and in vivo evaluation.
Tripathi CB; Parashar P; Arya M; Singh M; Kanoujia J; Kaithwas G; Saraf SA
Drug Deliv Transl Res; 2018 Oct; 8(5):1313-1334. PubMed ID: 29748834
[TBL] [Abstract][Full Text] [Related]
74. In vivo activity of a PSA-activated doxorubicin prodrug against PSA-producing human prostate cancer xenografts.
Khan SR; Denmeade SR
Prostate; 2000 Sep; 45(1):80-3. PubMed ID: 10960846
[TBL] [Abstract][Full Text] [Related]
75. Disparate impact of butyroyloxymethyl diethylphosphate (AN-7), a histone deacetylase inhibitor, and doxorubicin in mice bearing a mammary tumor.
Tarasenko N; Cutts SM; Phillips DR; Inbal A; Nudelman A; Kessler-Icekson G; Rephaeli A
PLoS One; 2012; 7(2):e31393. PubMed ID: 22384017
[TBL] [Abstract][Full Text] [Related]
76. Non-toxic Efficacy of the Combination of Caffeine and Valproic Acid on Human Osteosarcoma Cells In Vitro and in Orthotopic Nude-mouse Models.
Igarashi K; Yamamoto N; Hayashi K; Takeuchi A; Kimura H; Miwa S; Hoffman RM; Tsuchiya H
Anticancer Res; 2016 Sep; 36(9):4477-82. PubMed ID: 27630284
[TBL] [Abstract][Full Text] [Related]
77. Phase I pharmacokinetic and pharmacodynamic evaluation of combined valproic acid/doxorubicin treatment in dogs with spontaneous cancer.
Wittenburg LA; Gustafson DL; Thamm DH
Clin Cancer Res; 2010 Oct; 16(19):4832-42. PubMed ID: 20705615
[TBL] [Abstract][Full Text] [Related]
78. Protective and anticancer effects of orange peel extract and naringin in doxorubicin treated esophageal cancer stem cell xenograft tumor mouse model.
Tajaldini M; Samadi F; Khosravi A; Ghasemnejad A; Asadi J
Biomed Pharmacother; 2020 Jan; 121():109594. PubMed ID: 31707344
[TBL] [Abstract][Full Text] [Related]
79. Ellagic acid synergistically potentiates inhibitory activities of chemotherapeutic agents to human hepatocellular carcinoma.
Zhong C; Qiu S; Li J; Shen J; Zu Y; Shi J; Sui G
Phytomedicine; 2019 Jun; 59():152921. PubMed ID: 31055231
[TBL] [Abstract][Full Text] [Related]
80. A comparative study of the antitumor efficacy of peptide-doxorubicin conjugates with different linkers.
Liang Y; Li S; Wang X; Zhang Y; Sun Y; Wang Y; Wang X; He B; Dai W; Zhang H; Wang X; Zhang Q
J Control Release; 2018 Apr; 275():129-141. PubMed ID: 29408580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
